Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go

Bone Marrow Transplantation volume 44, pages 137–143 (2009)Cite this article

Abstract

In children, autoimmune diseases and their therapies cause significant morbidity, especially in those with severe or refractory disease. The constant development of new immunosuppressants and targeted biological therapies leads to a unique ‘moving target’ with regard to the gold standard of treatment for these patients. However, incidental findings of cure after hematopoietic stem cell transplant (HSCT) in patients with concomitant benign or malignant hematologic disorders and autoimmune disease raise the question of whether HSCT can be used as upfront therapy for patients with severe autoimmune diseases. Animal data have been helpful in investigating both the efficacy of this modality and the mechanisms underlying cure. The potential for a therapeutic ‘graft vs autoimmunity’ (GVA) effect with an allogeneic approach highlights the already acknowledged need for clinical trials of allogeneic vs autologous transplant in these diseases where an autologous transplant would be the ‘intuitive’ albeit potentially erroneous choice. We critically review the data generated in the field thus far, and emphasize the need for an organized, interdisciplinary approach to conduct prospective clinical trials to answer these and other questions and advance the field.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ravelli A, Martini A . Juvenile idiopathic arthritis. Lancet 2007; 369: 767–778.

    Article  CAS  PubMed  Google Scholar 

  2. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 501–507.

    Article  PubMed  Google Scholar 

  3. Ruperto N, Martini A . Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization. World J Pediatr 2008; 4: 186–191.

    Article  PubMed  Google Scholar 

  4. Wallace CA . Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006; 20: 279–300.

    Article  PubMed  Google Scholar 

  5. Tyndall A, Gratwohl A . Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996; 55: 149–151.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Eedy DJ, Burrows D, Bridges JM, Jones FG . Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990; 300: 908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Jacobs P, Vincent MD, Martell RW . Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1986; 1: 237–239.

    CAS  PubMed  Google Scholar 

  8. Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643–645.

    Article  CAS  PubMed  Google Scholar 

  9. Rabusin M, Andolina M, Maximova N . Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives. Bone Marrow Transplant 2008; 41 (Suppl 2): S96–S99.

    Article  PubMed  Google Scholar 

  10. Baldwin JL, Storb R, Thomas ED, Mannik M . Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 1977; 20: 1043–1048.

    Article  CAS  PubMed  Google Scholar 

  11. Meloni G, Capria S, Vignetti M, Mandelli F, Modena V . Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. Blood 1997; 89: 4659.

    CAS  PubMed  Google Scholar 

  12. Hinterberger W, Hinterberger-Fischer M, Marmont A . Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753–759.

    Article  CAS  PubMed  Google Scholar 

  13. Burt RK, Verda L, Oyama Y, Statkute L, Slavin S . Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 2004; 26: 57–69.

    Article  PubMed  Google Scholar 

  14. Brinkman DM, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56: 2410–2421.

    Article  CAS  PubMed  Google Scholar 

  15. Gratwohl A, Passweg J, Gerber I, Tyndall A . Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 2001; 14: 755–776.

    Article  CAS  PubMed  Google Scholar 

  16. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621–3625.

    CAS  PubMed  Google Scholar 

  17. Brinkman DM, Jol-van der Zijde CM, ten Dam MM, te Boekhorst PA, ten Cate R, Wulffraat NM et al. Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines. J Clin Immunol 2007; 27: 647–658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mellouli F, Ksouri H, Torjmen L, Abdelkefi A, Ladeb S, Ben Othman T et al. Transmission of type 1 diabetes by bone marrow transplantation: a case report. Pediatr Transplant 2009; 13: 119–122.

    Article  PubMed  Google Scholar 

  19. Marazuela M, Steegman JL . Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease. Bone Marrow Transplant 2000; 26: 1217–1220.

    Article  CAS  PubMed  Google Scholar 

  20. Berisso GA, van Lint MT, Bacigalupo A, Marmont AM . Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease. Bone Marrow Transplant 1999; 23: 1091–1092.

    Article  CAS  PubMed  Google Scholar 

  21. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993; 341: 1243–1244.

    Article  CAS  PubMed  Google Scholar 

  22. Bargetzi MJ, Schonenberger A, Tichelli A, Fried R, Cathomas G, Signer E et al. Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1997; 20: 607–609.

    Article  CAS  PubMed  Google Scholar 

  23. Ritchie DS, Sainani A, D'Souza A, Grigg AP . Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation. Am J Hematol 2005; 79: 299–302.

    Article  CAS  PubMed  Google Scholar 

  24. Wicker LS, Miller BJ, Chai A, Terada M, Mullen Y . Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice. J Exp Med 1988; 167: 1801–1810.

    Article  CAS  PubMed  Google Scholar 

  25. Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.

    Article  CAS  PubMed  Google Scholar 

  26. Kojima R, Kami M, Kim SW, Murashige N, Kishi Y, Hori A et al. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 439–442.

    Article  CAS  PubMed  Google Scholar 

  27. Weissman IL, Shizuru JA . The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008; 112: 3543–3553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Alderuccio F, Chan J, Toh BH . Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease. Autoimmunity 2008; 28 (e-pub ahead of print).

  29. Alderuccio F, Siatskas C, Chan J, Field J, Murphy K, Nasa Z et al. Haematopoietic stem cell gene therapy to treat autoimmune disease. Curr Stem Cell Res Ther 2006; 1: 279–287.

    Article  CAS  PubMed  Google Scholar 

  30. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107: 1696–1702.

    Article  CAS  PubMed  Google Scholar 

  31. van Bekkum DW . Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases. J Leukoc Biol 2002; 72: 609–620.

    CAS  PubMed  Google Scholar 

  32. Morton JI, Siegel BV . Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974; 71: 2162–2165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Morton JI, Siegel BV . Transplantation of autoimmune potential. IV. Reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation 1979; 27: 133–134.

    Article  CAS  PubMed  Google Scholar 

  34. Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A . Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992; 148: 1693–1698.

    CAS  PubMed  Google Scholar 

  35. van Gelder M, van Bekkum DW . Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343–351.

    CAS  PubMed  Google Scholar 

  36. Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985; 82: 2483–2487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ikehara S, Kawamura M, Takao F, Inaba M, Yasumizu R, Than S et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 8341–8344.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ikehara S, Ohtsuki H, Good RA, Asamoto H, Nakamura T, Sekita K et al. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci USA 1985; 82: 7743–7747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sykes M, Nikolic B . Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435: 620–627.

    Article  CAS  PubMed  Google Scholar 

  40. Ikehara S . Stem cell transplantation for autoimmune diseases: what can we learn from experimental models? Autoimmunity 2008; 28 (e-pub ahead of print).

  41. Ikehara S . Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders. Ann NY Acad Sci 2005; 1051: 626–634.

    Article  PubMed  Google Scholar 

  42. Chan J, Ban EJ, Chun KH, Wang S, Backstrom BT, Bernard CC et al. Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 2008; 181: 7571–7580.

    Article  CAS  PubMed  Google Scholar 

  43. De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318–1326.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ferreira RA, Vastert SJ, Abinun M, Foster HE, Modesto C, Olive T et al. Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. Bone Marrow Transplant 2006; 38: 249–251.

    Article  CAS  PubMed  Google Scholar 

  45. Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 2003; 32 (Suppl 1): S61–S64.

    Article  CAS  PubMed  Google Scholar 

  46. Wulffraat NM, Sanders LA, Kuis W . Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2000; 2: 316–323.

    Article  CAS  PubMed  Google Scholar 

  47. Kishimoto T, Hamazaki T, Yasui M, Sasabe M, Okamura T, Sakata N et al. Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis. Int J Hematol 2003; 78: 453–456.

    Article  PubMed  Google Scholar 

  48. Chen J, Wang Y, Kunkel G, Zhao H, Xue H, Xie X et al. Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus. Clin Rheumatol 2005; 24: 464–468.

    Article  CAS  PubMed  Google Scholar 

  49. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869–879.

    Article  CAS  PubMed  Google Scholar 

  50. Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A et al. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 2006; 39: 505–511.

    Article  CAS  PubMed  Google Scholar 

  51. Urban C, Lackner H, Sovinz P, Benesch M, Schwinger W, Dornbusch HJ et al. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol 2006; 76: 526–530.

    Article  PubMed  Google Scholar 

  52. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn′s disease. Gastroenterology 2005; 128: 552–563.

    Article  PubMed  Google Scholar 

  53. Kline RM, Neudorf SM, Baron HI . Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia. Pediatrics 2007; 120: e1120–e1122.

    Article  PubMed  Google Scholar 

  54. Elhasid R, Rowe JM, Berkowitz D, Ben-Arush M, Bar-Shalom R, Brik R . Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004; 33: 1257–1259.

    Article  CAS  PubMed  Google Scholar 

  55. Jones OY, Cahill RA . Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis. Immunol Res 2008; 41: 26–33.

    Article  PubMed  Google Scholar 

  56. Rao A, Kamani N, Filipovich A, Lee SM, Davies SM, Dalal J et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007; 109: 383–385.

    Article  CAS  PubMed  Google Scholar 

  57. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143–149.

    Article  CAS  PubMed  Google Scholar 

  58. Bennett CL, Ochs HD . IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 2001; 13: 533–538.

    Article  CAS  PubMed  Google Scholar 

  59. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20–21.

    Article  CAS  PubMed  Google Scholar 

  60. Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758–1762.

    Article  CAS  PubMed  Google Scholar 

  61. Gambineri E, Torgerson TR, Ochs HD . Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430–435.

    Article  CAS  PubMed  Google Scholar 

  62. Mazzolari E, Forino C, Fontana M, D'Ippolito C, Lanfranchi A, Gambineri E et al. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 2005; 35: 1033–1034.

    Article  CAS  PubMed  Google Scholar 

  63. Wildin RS, Smyk-Pearson S, Filipovich AH . Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537–545.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168–176.

    Article  PubMed  Google Scholar 

  65. Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008; 67: 98–104.

    Article  CAS  PubMed  Google Scholar 

  66. Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004; 125: 749–755.

    Article  CAS  PubMed  Google Scholar 

  67. Milledge J, Shaw PJ, Mansour A, Williamson S, Bennetts B, Roscioli T et al. Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. Blood 2002; 100: 774–777.

    Article  CAS  PubMed  Google Scholar 

  68. De Stefano P, Zecca M, Giorgiani G, Perotti C, Giraldi E, Locatelli F . Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft. Br J Haematol 1999; 106: 1063–1064.

    Article  CAS  PubMed  Google Scholar 

  69. Gassas A, Sung L, Saunders EF, Doyle JJ . Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Bone Marrow Transplant 2006; 38: 739–743.

    Article  CAS  PubMed  Google Scholar 

  70. Dvorak CC, Agarwal R, Dahl GV, Gregory JJ, Feusner JH . Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. Biol Blood Marrow Transplant 2008; 14: 824–830.

    Article  PubMed  PubMed Central  Google Scholar 

  71. MacMillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14 (9 Suppl): 16–22.

    Article  PubMed  Google Scholar 

  72. Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schonberger S et al. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Biol Blood Marrow Transplant 2007; 13: 1338–1345.

    Article  PubMed  Google Scholar 

  73. Ilowite NT . Update on biologics in juvenile idiopathic arthritis. Curr Opin Rheumatol 2008; 20: 613–618.

    Article  PubMed  Google Scholar 

  74. Lepore L, Kiren V . Autologous bone marrow transplantation versus alternative drugs in pediatric rheumatic diseases. Haematologica 2000; 85 (11 Suppl): 89–92.

    CAS  PubMed  Google Scholar 

  75. Petty RE . Prognosis in children with rheumatic disease; justification for consideration of new therapies. Rheumatology (Oxford) 1999; 38: 739–742.

    Article  CAS  Google Scholar 

  76. Peschken CA, Esdaile JM . Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 2000; 27: 1884–1891.

    CAS  PubMed  Google Scholar 

  77. Moss KE, Isenberg DA . Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone. Rheumatology (Oxford) 2001; 40: 863–867.

    Article  CAS  Google Scholar 

  78. Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006; 54: 3971–3978.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Stem Cell Transplantation and Immunology,

    A C Krauss & N R Kamani

  2. Children's National Medical Center, Washington, DC, USA

    A C Krauss & N R Kamani

  3. Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC, USA

    N R Kamani

Authors
  1. A C Krauss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N R Kamani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N R Kamani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krauss, A., Kamani, N. Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. Bone Marrow Transplant 44, 137–143 (2009). https://doi.org/10.1038/bmt.2009.147

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.147

Keywords

This article is cited by

Search

Advanced search

Quick links